Cyclops MedTech

Bengaluru, India Founded: 2015 • Age: 11 yrs Minicorn
Provider of an AI and VR-based eye tracking solution for eye balancing and testing

About Cyclops MedTech

Cyclops MedTech is a Healthcare company based in Bengaluru (India) founded in 2015 by Ravi Nayar, Srinivas Rammanna Dorasala, and Niranjan Subbarao. Provider of an AI and VR-based eye tracking solution for eye balancing and testing. It operates in the Healthcare and Technology sectors. Cyclops MedTech has raised $1.25 million across 5 funding rounds from investors including Biocon, Molecular Connections and Enzia. The company has 25 employees. Cyclops MedTech was last valued at $3.45 million in June 2018. Its chief executive, as recorded, is Niranjan Subbarao. Its Indian entity Cyclops Medtech Private Limited reported revenue of β‚Ή4.89 Cr. Cyclops MedTech offers products and services including BalanceEye VOG, BalanceEye vHIT, and BalanceEye VRT. Its focus areas include HealthTech, Assistive Tech, Assistive Software and VR Accessibility. Its competitors include Forus Health and Remidio; 2 of its 2 listed competitors have raised funding.

Company details

Cyclops MedTech was founded in 2015 in Bengaluru, India, as a provider of AI and VR-based eye tracking tools in the medtech sector. Operations focus on a wearable head-mounted display device used for clinical assessment of conditions including vertigo, migraine, epilepsy, concussion, and ADHD. A prototype in the form of spectacles equipped with eye-tracking cameras and sensors is developed to capture data during episodes.

  • Headquarters Bengaluru, India
  • Employees 25
  • Founders Ravi Nayar, Srinivas Rammanna Dorasala, Niranjan Subbarao
  • Stage Minicorn
  • Sectors
    Healthcare
    Technology
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website cyclopsmedtech.com
  • Social LinkedIn X Facebook YouTube
  • Legal Name Cyclops Medtech Private Limited
  • Date of Incorporation 29 Jan, 2015
  • Jurisdiction Bangalore, Karnataka, India
Key Metrics
  • Annual Revenue
    ₹4.89 Cr

    FY 2023 · +19% YoY

  • Net Profit
    ₹13.7 Lakh

    FY 2023 · 3% margin

  • EBITDA
    ₹2.7 Lakh

    FY 2023 · 1% margin

  • Total Equity Funding
    $1.25M (USD)

    in 5 rounds

  • Investors
    Biocon

    & 11 more

  • Employee Count
    25

Products & Services of Cyclops MedTech

Cyclops MedTech offers a comprehensive portfolio of products and services, including BalanceEye VOG, BalanceEye vHIT, and BalanceEye VRT.

BalanceEye VOG
Diagnostic Tool

Videography for eye movement to assess dizziness and balance disorders.

BalanceEye vHIT
Diagnostic Tool

Tests head impulses for evaluating vestibular function accurately.

BalanceEye VRT
Therapy Tool

Virtual reality system for vestibular rehabilitation and balance training.

Apps and channels of Cyclops MedTech

its YouTube channel Cyclops Learning Lab has 4.32K subscribers and 30 videos.

Cyclops Learning Lab
YouTube 4.32K subscribers 30 videos Science & Technology
Open channel

Videos from Cyclops MedTech

The most watched videos on Cyclops MedTech's YouTube channel, Cyclops Learning Lab (4.32K subscribers). Click a video to play it here.

Appiani Manoeuvre - Right
1.8K views
Lempert Barbecue Roll
1.7K views
Bangalore Manoeuvre
1.4K views
Cyclops Medtech - product montage
887 views

More on Cyclops Learning Lab.

Funding Insights of Cyclops MedTech

Cyclops MedTech has successfully raised a total of $1.25M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $1.25M
  • Total Rounds 5
  • Investors Count 12

All 5 funding rounds of Cyclops MedTech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2020$100,000Seed–Enzia, Indian Angel Network
–
Dec 2020Grant––
Jun 2018$1MSeed$3.45MCapria
May 2016$148,734Seed$1.16M–
Jan 2015Seed––
–
Valuation history
DateValuationStage
Jun 2018$3.45Mβ€’β€’β€’β€’β€’β€’β€’β€’
May 2016$1.16Mβ€’β€’β€’β€’β€’β€’β€’β€’

Last known valuation $3.45M (Jun 2018). 12 investors in total: 9 institutional and 3 angel.

Investors in Cyclops MedTech

Cyclops MedTech has secured backing from 12 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Biocon, Molecular Connections and Enzia.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Investments in healthcare, education, and environment sectors through technology-driven solutions.
2019enzia.vcBengaluru, India
Angel investor network investing in early-stage startups
iangroup.vcDelhi, India
Venture capital firm investing in applied generative AI
capria.vcSeattle, United States
Sector-agnostic startups are accelerated by SINE, backed by IIT Bombay.
sineiitb.orgMumbai, India
Supporting startups with India scale and global potential through venture advisory and partnerships.
unitus.vc
Databases and analytics for drug discovery are provided.
2002molecularconnections.comBengaluru, India
Drug R&D services are provided for multiple therapeutic areas.
1978biocon.comBengaluru, India

C P Bothra

unknown_ce265173f8ed46438
Premium access

Investor details for Cyclops MedTech

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Cyclops Medtech Private Limited (Cyclops MedTech)

Cyclops Medtech Private Limited is the primary company behind Cyclops MedTech. The board of Cyclops Medtech Private Limited currently have 4 directors; the longest-serving is Ravi Chandran Nayar, appointed in 2015.

DirectorDesignationAppointedTenureEntity
Ravi Chandran Nayar
DIN 07043276
Director29 Jan 201511 yrs 9 moCyclops Medtech Private Limited
Dorasala Rammanna Srinivas
DIN 07043290
Director29 Jan 201511 yrs 9 moCyclops Medtech Private Limited
Niranjan Mysore Subbarao
DIN 03032895
Director29 Jan 201511 yrs 9 moCyclops Medtech Private Limited
Chandanmal Pukhraj Bothra
DIN 00023108
Nominee Director09 Jul 20188 yrs 3 moCyclops Medtech Private Limited

People of Cyclops MedTech

6 people are tracked at Cyclops MedTech (4 in leadership, 2 in team); the tracked headcount is 25.

NameRoleGroup
Co-FounderLeadership
Co-FounderLeadership
Co-Founder & CEOLeadership
Co-Founder & Head, Product InnovationLeadership
Abhishek Bhat
Area Sales ManagerTeam
Pramod Manjunath
Lead - Regulatory Affairs & New InitiativesTeam
Premium access

Complete people profiles for Cyclops MedTech

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Cyclops MedTech

Figures of Cyclops Medtech Private Limited, the primary company behind Cyclops MedTech, for FY 2023. Revenue was ₹4.89 Cr (+19% year on year). Net profit was ₹13.7 Lakh (3% margin). EBITDA was ₹2.7 Lakh (1% margin). Revenue has grown at a compounded annual rate of +24% over three years and +28% over five years.

  • ₹4.89 CrRevenue · FY 2023 · +19% YoY
  • ₹13.7 LakhNet profit · 3% margin
  • ₹2.7 LakhEBITDA · 1% margin
  • ₹1.6 LakhPaid-up capital
  • 25Employees (provident fund records)
  • +24%Revenue CAGR, 3 years
  • +28%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Cyclops Medtech Private Limited are on its company page.

Premium access

Detailed financial statements for Cyclops MedTech

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Cyclops MedTech

4 dated milestones of Cyclops MedTech across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Cyclops MedTech is founded.
  2. Funding First funding round.
  3. Milestone Reaches Minicorn status.
  4. Funding Latest funding round, Grant,.

Competitors of Cyclops MedTech

Cyclops MedTech has 2 listed competitors in our database, 2 of them funded. They include Forus Health and Remidio.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
forushealth.com2010Bengaluru, India$18.12M171
Manufacturer of portable digital eye imaging devices and cloud-based healthcare platforms
remidio.com2009Bengaluru, India$25.01M164
AI-powered portable solutions for ophthalmic screening and diagnosis are developed.
Premium access

Detailed competitors of Cyclops MedTech

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Cyclops MedTech

The website of Cyclops MedTech (cyclopsmedtech.com) receives about 1.3K visits a month.

  • Monthly visits
    1.3K

    ▲ 27.4% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Cyclops Medtech

Premium access

Complete news archive for Cyclops MedTech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Cyclops MedTech

Cyclops MedTech was founded in 2015.

Cyclops MedTech is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

Niranjan Subbarao is the CEO of Cyclops MedTech, as recorded in our data. They have also founded this company.

Cyclops MedTech is a funded company, having raised a total of $1.25M across 5 funding rounds to date.

Cyclops MedTech has 25 employees.

The primary company behind Cyclops MedTech, Cyclops Medtech Private Limited, reported revenue of β‚Ή4.89 Cr for FY 2023, up 19% year on year.

Cyclops MedTech was founded in 2015 in Bengaluru, India, as a provider of AI and VR-based eye tracking tools in the medtech sector. Operations focus on a wearable head-mounted display device used for clinical assessment of conditions including vertigo, migraine, epilepsy, concussion, and ADHD. A prototype in the form of spectacles equipped with eye-tracking cameras and sensors is developed to capture data during episodes.

Cyclops MedTech's top competitors include Remidio and Forus Health.

Cyclops MedTech offers BalanceEye VOG, BalanceEye vHIT, and BalanceEye VRT.

Cyclops MedTech has 12 investors. Key investors include Biocon, Molecular Connections, Enzia, Indian Angel Network, and Capria.

The valuation of Cyclops MedTech is $3.45M as of Jun 2018.

Cyclops MedTech operates through Cyclops Medtech Private Limited.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available